Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
50.94
|
2
|
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
41.47
|
3
|
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
26.95
|
4
|
Grand challenges in global mental health.
|
Nature
|
2011
|
8.40
|
5
|
Effects of a sustained heroin shortage in three Australian States.
|
Addiction
|
2005
|
6.62
|
6
|
Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
|
Lancet
|
2012
|
6.36
|
7
|
An invitation to an alcohol industry lobby to help decide public funding of alcohol research and professional training: a decision that should be reversed.
|
Addiction
|
2004
|
5.61
|
8
|
Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.
|
Addiction
|
2012
|
3.91
|
9
|
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
|
Psychol Med
|
2007
|
3.45
|
10
|
Addiction, neuroscience and ethics.
|
Addiction
|
2003
|
3.44
|
11
|
The integrity of the science base: a test case.
|
Addiction
|
2005
|
3.40
|
12
|
Cannabis use and mental health in young people: cohort study.
|
BMJ
|
2002
|
3.26
|
13
|
Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol.
|
Addiction
|
2013
|
3.24
|
14
|
Exploring the association between cannabis use and depression.
|
Addiction
|
2003
|
2.92
|
15
|
Ethical concerns in the community about technologies to extend human life span.
|
Am J Bioeth
|
2009
|
2.87
|
16
|
Heroin overdose: research and evidence-based intervention.
|
J Urban Health
|
2003
|
2.66
|
17
|
Is cannabis use a contributory cause of psychosis?
|
Can J Psychiatry
|
2006
|
2.42
|
18
|
Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland.
|
BMJ
|
2010
|
2.41
|
19
|
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
|
Drug Alcohol Depend
|
2009
|
2.20
|
20
|
Proposals to trial deep brain stimulation to treat addiction are premature.
|
Addiction
|
2011
|
2.17
|
21
|
Compulsory detention, forced detoxification and enforced labour are not ethically acceptable or effective ways to treat addiction.
|
Addiction
|
2012
|
2.15
|
22
|
A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.
|
Drug Alcohol Depend
|
2003
|
2.05
|
23
|
Heroin-assisted treatment as a response to the public health problem of opiate dependence.
|
Eur J Public Health
|
2002
|
1.89
|
24
|
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations.
|
Can J Public Health
|
2011
|
1.81
|
25
|
Causes of death in a cohort treated for opioid dependence between 1985 and 2005.
|
Addiction
|
2013
|
1.64
|
26
|
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain.
|
Pain
|
2015
|
1.62
|
27
|
Trajectories of adolescent alcohol and cannabis use into young adulthood.
|
Addiction
|
2007
|
1.60
|
28
|
Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies.
|
Int J Drug Policy
|
2009
|
1.53
|
29
|
Testing hypotheses about the relationship between cannabis use and psychosis.
|
Drug Alcohol Depend
|
2003
|
1.49
|
30
|
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization.
|
Pain Med
|
2014
|
1.49
|
31
|
Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
|
Drug Alcohol Rev
|
2008
|
1.44
|
32
|
What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews.
|
Drug Alcohol Depend
|
2011
|
1.43
|
33
|
Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS).
|
Addiction
|
2002
|
1.42
|
34
|
Drug trafficking: time to abolish the death penalty.
|
Addiction
|
2009
|
1.41
|
35
|
Standardizing terminology in addiction science: to achieve the impossible dream.
|
Addiction
|
2007
|
1.39
|
36
|
Systematic review of interventions to improve prescribing.
|
Ann Pharmacother
|
2009
|
1.35
|
37
|
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use.
|
Drug Alcohol Rev
|
2010
|
1.24
|
38
|
Mortality among amphetamine users: a systematic review of cohort studies.
|
Drug Alcohol Depend
|
2009
|
1.21
|
39
|
Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
|
Addiction
|
2010
|
1.20
|
40
|
A systematic review of research examining benzodiazepine-related mortality.
|
Pharmacoepidemiol Drug Saf
|
2009
|
1.18
|
41
|
Epidemiology of alcohol-related burden of disease among Indigenous Australians.
|
Aust N Z J Public Health
|
2010
|
1.17
|
42
|
Another mirror shattered? Tobacco industry involvement suspected in a book which claims that nicotine is not addictive.
|
Addiction
|
2002
|
1.13
|
43
|
Decreased heroin availability in Sydney in early 2001.
|
Addiction
|
2003
|
1.13
|
44
|
Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence.
|
Addict Behav
|
2010
|
1.12
|
45
|
Psychosis in Indigenous populations of Cape York and the Torres Strait.
|
Med J Aust
|
2012
|
1.12
|
46
|
Beware of allowing the ideal to be the enemy of the good.
|
Addiction
|
2011
|
1.09
|
47
|
Ending inequities in access to effective pain relief?
|
Lancet
|
2010
|
1.09
|
48
|
The ethics of paying drug users who participate in research: a review and practical recommendations.
|
J Empir Res Hum Res Ethics
|
2006
|
1.07
|
49
|
Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes.
|
BMJ
|
2004
|
1.03
|
50
|
Patterns of co-morbidity between alcohol use and other substance use in the Australian population.
|
Drug Alcohol Rev
|
2003
|
1.03
|
51
|
Hair morphine concentrations of fatal heroin overdose cases and living heroin users.
|
Addiction
|
2002
|
1.02
|
52
|
Mobile Phones in Research and Treatment: Ethical Guidelines and Future Directions.
|
JMIR Mhealth Uhealth
|
2015
|
1.02
|
53
|
Evaluating explanations of the Australian 'heroin shortage'.
|
Addiction
|
2005
|
1.01
|
54
|
Analysis of socio-political and health practices influencing sex ratio at birth in Viet Nam.
|
Reprod Health Matters
|
2008
|
1.01
|
55
|
The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence.
|
Drug Alcohol Depend
|
2005
|
1.01
|
56
|
Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety.
|
Drug Alcohol Rev
|
2012
|
1.00
|
57
|
The "lessons" of the Australian "heroin shortage".
|
Subst Abuse Treat Prev Policy
|
2006
|
0.99
|
58
|
Getting the cannabis withdrawal question into proper perspective: comments on Smith.
|
Addiction
|
2002
|
0.99
|
59
|
Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example.
|
BMC Med Res Methodol
|
2006
|
0.98
|
60
|
Stereotactic neurosurgical treatment of addiction: minimizing the chances of another 'great and desperate cure'.
|
Addiction
|
2006
|
0.96
|
61
|
Cannabis use in Canada: the need for a 'public health' approach.
|
Can J Public Health
|
2009
|
0.95
|
62
|
Alcohol and other drug use disorders among older-aged people.
|
Drug Alcohol Rev
|
2003
|
0.94
|
63
|
Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment.
|
Water Res
|
2011
|
0.94
|
64
|
Establishing and Governing e-Mental Health Care in Australia: A Systematic Review of Challenges and A Call For Policy-Focussed Research.
|
J Med Internet Res
|
2016
|
0.93
|
65
|
British drinking: a suitable case for treatment?
|
BMJ
|
2005
|
0.92
|
66
|
Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential.
|
Med J Aust
|
2013
|
0.91
|
67
|
Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.
|
EMBO Rep
|
2013
|
0.90
|
68
|
The persistence of adolescent binge drinking into adulthood: findings from a 15-year prospective cohort study.
|
BMJ Open
|
2013
|
0.89
|
69
|
The potential role of snus in tobacco harm reduction.
|
Addiction
|
2009
|
0.88
|
70
|
Thinking about the unthinkable: a de facto prohibition on smoked tobacco products.
|
Addiction
|
2008
|
0.88
|
71
|
Documenting the heroin shortage in New South Wales.
|
Drug Alcohol Rev
|
2006
|
0.88
|
72
|
Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
|
Neurocase
|
2011
|
0.87
|
73
|
The issue of consent in research that administers drugs of addiction to addicted persons.
|
Account Res
|
2008
|
0.87
|
74
|
Informed consent to opioid agonist maintenance treatment: recommended ethical guidelines.
|
Int J Drug Policy
|
2008
|
0.87
|
75
|
Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.
|
Aust N Z J Psychiatry
|
2012
|
0.87
|
76
|
How will information about the genetic risk of mental disorders impact on stigma?
|
Aust N Z J Psychiatry
|
2008
|
0.86
|
77
|
Cannabis and the increased incidence and persistence of psychosis.
|
BMJ
|
2011
|
0.86
|
78
|
E-cigarettes and the law in Australia.
|
Aust Fam Physician
|
2015
|
0.86
|
79
|
Preventing drug misuse by young people: we need to do more than 'just say no'.
|
Addiction
|
2002
|
0.86
|
80
|
Public attitudes towards the acceptability of using drugs to treat depression and ADHD.
|
Aust N Z J Psychiatry
|
2012
|
0.85
|
81
|
Who wants to live forever?
|
EMBO Rep
|
2005
|
0.85
|
82
|
Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.
|
Drug Alcohol Depend
|
2005
|
0.85
|
83
|
Testing for cannabis in the work-place: a review of the evidence.
|
Addiction
|
2010
|
0.85
|
84
|
Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: evidence from national cross-sectional surveys.
|
Aust N Z J Psychiatry
|
2010
|
0.84
|
85
|
Cannabis and psychosis.
|
Curr Psychiatry Rep
|
2002
|
0.84
|
86
|
Forecasting future tobacco control policy: where to next?
|
Aust N Z J Public Health
|
2010
|
0.84
|
87
|
Mental disorders and socioeconomic status: impact on population risk of attempted suicide in australia.
|
Suicide Life Threat Behav
|
2009
|
0.84
|
88
|
Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD.
|
BMC Psychiatry
|
2014
|
0.83
|
89
|
Harm reduction policies for tobacco users.
|
Int J Drug Policy
|
2009
|
0.83
|
90
|
The implications of genetic susceptibility for the prevention of colorectal cancer: a qualitative study of older adults' understanding.
|
Community Genet
|
2008
|
0.83
|
91
|
Changes in the initiation of heroin use after a reduction in heroin supply.
|
Drug Alcohol Rev
|
2006
|
0.81
|
92
|
Is deep brain stimulation a prospective "cure" for addiction?
|
F1000 Med Rep
|
2011
|
0.81
|
93
|
Avoiding selective ethical objections to nudges.
|
Am J Bioeth
|
2012
|
0.81
|
94
|
Cannabis use and cancer.
|
Addiction
|
2002
|
0.81
|
95
|
Ethical, social, and personal implications of extended human lifespan identified by members of the public.
|
Rejuvenation Res
|
2009
|
0.81
|
96
|
Public attitudes in Australia towards the claim that addiction is a (brain) disease.
|
Drug Alcohol Rev
|
2014
|
0.81
|
97
|
Statins down under.
|
Br J Clin Pharmacol
|
2006
|
0.81
|
98
|
The perceived health risks of cannabis use in an Australian household survey.
|
Drug Alcohol Rev
|
2012
|
0.80
|
99
|
Differences in associations between cannabis and stimulant disorders in first admission psychosis.
|
Schizophr Res
|
2013
|
0.80
|
100
|
Regulating opioid prescribing to provide access to effective treatment while minimizing diversion: an overdue topic for research.
|
Addiction
|
2007
|
0.80
|
101
|
A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010).
|
AIDS Res Hum Retroviruses
|
2013
|
0.80
|
102
|
Heroin addiction and the capacity for consent: a reply to Charland.
|
Addiction
|
2003
|
0.80
|
103
|
Delivering on the promise of human stem-cell research. What are the real barriers?
|
EMBO Rep
|
2006
|
0.80
|
104
|
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.
|
Am J Public Health
|
2017
|
0.79
|
105
|
The search for Methuselah. Should we endeavour to increase the maximum human lifespan?
|
EMBO Rep
|
2007
|
0.79
|
106
|
Excess mortality among opioid-using patients treated with oral naltrexone in Australia.
|
Drug Alcohol Rev
|
2014
|
0.78
|
107
|
Prevalence and Correlates of Suicidal Thoughts and Suicide Attempts in People Prescribed Pharmaceutical Opioids for Chronic Pain.
|
Clin J Pain
|
2016
|
0.78
|
108
|
State of the nation's mental health 2007.
|
Aust N Z J Psychiatry
|
2009
|
0.78
|
109
|
Factors influencing women's decisions to drink alcohol during pregnancy: findings of a qualitative study with implications for health communication.
|
BMC Pregnancy Childbirth
|
2014
|
0.78
|
110
|
Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?
|
Addiction
|
2011
|
0.78
|
111
|
Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi-rural and a vacation area.
|
Addiction
|
2012
|
0.78
|
112
|
Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
|
BMC Public Health
|
2005
|
0.78
|
113
|
Stimulant use disorders: characteristics and comorbidity in an Australian population sample.
|
Aust N Z J Psychiatry
|
2012
|
0.77
|
114
|
Should doctors prescribe cannabinoids?
|
BMJ
|
2014
|
0.77
|
115
|
A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence.
|
Drug Alcohol Rev
|
2013
|
0.77
|
116
|
Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter?
|
Addiction
|
2009
|
0.77
|
117
|
A randomized clinical trial of a financial education intervention with nicotine replacement therapy (NRT) for low socio-economic status Australian smokers: a study protocol.
|
Addiction
|
2014
|
0.77
|
118
|
The social implications of neurobiological explanations of resistible compulsions.
|
Am J Bioeth
|
2007
|
0.77
|
119
|
Public attitudes toward the treatment of nicotine addiction.
|
Nicotine Tob Res
|
2013
|
0.77
|
120
|
Alcohol industry and government revenue derived from underage drinking by Australian adolescents 2005.
|
Addict Behav
|
2008
|
0.77
|
121
|
Analysis of national data shows mixed evidence of hardening among Australian smokers.
|
Aust N Z J Public Health
|
2012
|
0.77
|
122
|
The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
|
BMC Public Health
|
2005
|
0.77
|
123
|
The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006.
|
Aust N Z J Public Health
|
2010
|
0.76
|
124
|
Systematic and day-to-day effects of chemical-derived population estimates on wastewater-based drug epidemiology.
|
Environ Sci Technol
|
2015
|
0.76
|
125
|
Ethical implications of research on craving.
|
Addict Behav
|
2012
|
0.76
|
126
|
Collecting real-time data from substance users raises unique legal and ethical issues: reply to Kuntsche & Labhart.
|
Addiction
|
2014
|
0.76
|
127
|
The psychotogenic effects of cannabis use: challenges in reducing residual uncertainties and communicating the risks.
|
Addiction
|
2004
|
0.76
|
128
|
Using quantitative wastewater analysis to measure daily usage of conventional and emerging illicit drugs at an annual music festival.
|
Drug Alcohol Rev
|
2013
|
0.75
|
129
|
In the face of uncertainty about the risks of low-level drinking, abstinence is prudent, not misogynistic, advice.
|
Am J Bioeth
|
2011
|
0.75
|
130
|
Listening to public concerns about human life extension. The public view of life-extension technologies is more nuanced than expected and researchers must engage in discussions if they hope to promote awareness and acceptance.
|
EMBO Rep
|
2010
|
0.75
|
131
|
Addiction editors respond to Mr. Leverton.
|
Addiction
|
2014
|
0.75
|
132
|
Smoking and mental health in young women – challenges in interpretation : a reply.
|
Psychol Med
|
2013
|
0.75
|
133
|
Response to reitan.
|
Addiction
|
2013
|
0.75
|
134
|
Begging important questions about cognitive enhancement, again.
|
Am J Bioeth
|
2011
|
0.75
|
135
|
Australian heroin seizures and the causes of the 2001 heroin shortage.
|
Int J Drug Policy
|
2008
|
0.75
|
136
|
Is deep brain stimulation for addiction an acceptable crime control measure?
|
Addiction
|
2012
|
0.75
|
137
|
Scare-mongering and the anticipatory ethics of experimental technologies.
|
Am J Bioeth
|
2009
|
0.75
|
138
|
Commentary on Kelty & Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?
|
Addiction
|
2012
|
0.75
|
139
|
Persons and personification.
|
Am J Bioeth
|
2007
|
0.75
|
140
|
Canadian heroin supply and the Australian 'heroin shortage'.
|
Addiction
|
2006
|
0.75
|
141
|
Mapping community concerns about radical extensions of human life expectancy.
|
Am J Bioeth
|
2009
|
0.75
|
142
|
Response to commentaries: Slowing down the rush to translation in personal genomics.
|
Addiction
|
2012
|
0.75
|
143
|
Stimulating debate in the field of addiction.
|
Addiction
|
2012
|
0.75
|
144
|
Driving while under the influence of cannabis.
|
BMJ
|
2012
|
0.75
|
145
|
Ensuring that addiction science is deserving of public trust.
|
Addiction
|
2006
|
0.75
|
146
|
A prospectus for ethical analysis of ageing individuals' responsibility to prevent cognitive decline.
|
Bioethics
|
2017
|
0.75
|
147
|
Commentary on Ort et al. (2014): What next to deliver on the promise of large scale sewage-based drug epidemiology?
|
Addiction
|
2014
|
0.75
|
148
|
Alcohol, tobacco, and prescription drugs: the relationship with illicit drugs in the treatment of substance users.
|
Subst Use Misuse
|
2012
|
0.75
|
149
|
What would evidence-informed drug policies look like?
|
Addiction
|
2010
|
0.75
|
150
|
Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia.
|
Drug Alcohol Rev
|
2013
|
0.75
|
151
|
National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story.
|
Australas Psychiatry
|
2013
|
0.75
|
152
|
Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease.
|
Expert Rev Pharmacoecon Outcomes Res
|
2007
|
0.75
|
153
|
Avoiding potential misuses of addiction brain science.
|
Addiction
|
2006
|
0.75
|
154
|
A renewed call for action on alcohol policy.
|
Addiction
|
2010
|
0.75
|
155
|
Patterns of tobacco smoking among illicit drug users in Australia 2001-2010.
|
Drug Alcohol Rev
|
2014
|
0.75
|
156
|
Research methods and statistical techniques in addiction.
|
Addiction
|
2012
|
0.75
|
157
|
Community attitudes to the regulation of life extension.
|
Ann N Y Acad Sci
|
2007
|
0.75
|
158
|
Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?
|
Pain
|
2016
|
0.75
|